Mar Albà 's evolutionary genomics LAB: Publications

Boll, L., Vázquez Montes de Oca, S., Camarena, M.E., Castelo, R, Bellmunt J, Perera-Bel, J., Albà, M.M. 2025

Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts

Nature Communications 16(1):1213

Camarena, M.E., Theunissen, P., Ruiz, M., Ruiz-Orera, J., Calvo-Serra, B., Castelo, R., Castro, C., Sarobe, P., Fortes, P. * , Perera-Bel, J. * , Albà, M.M. 2024

Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer meta-cohort

Science Advances 10 (28):eadn3628

Boll, L. #, Perera-Bel, J. #, Rodríguez-Vida, A., Arpí, O., Rovira, A., Juanpere, N., Vázquez, S., Hernández-Llodrà, S., Lloreta, J., Albà, M.M. *, Bellmunt, J. * 2023

The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer.

Scientific Reports 13:15287

de Jong, J.J., Valderrama, B.P., Perera-Bel, J., Juanpere, N., Cejas, P., Long, H., Albà, M.M., Gibb, E.A., Bellmunt, J. 2022

Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis

British Journal of Cancer 127(2):313-320